198 related articles for article (PubMed ID: 31344802)
1. Development and Optimization of Alpha-Pinene-Loaded Solid Lipid Nanoparticles (SLN) Using Experimental Factorial Design and Dispersion Analysis.
Zielińska A; Ferreira NR; Durazzo A; Lucarini M; Cicero N; Mamouni SE; Silva AM; Nowak I; Santini A; Souto EB
Molecules; 2019 Jul; 24(15):. PubMed ID: 31344802
[TBL] [Abstract][Full Text] [Related]
2. Optimization of linalool-loaded solid lipid nanoparticles using experimental factorial design and long-term stability studies with a new centrifugal sedimentation method.
Pereira I; Zielińska A; Ferreira NR; Silva AM; Souto EB
Int J Pharm; 2018 Oct; 549(1-2):261-270. PubMed ID: 30075252
[TBL] [Abstract][Full Text] [Related]
3. Loading, release profile and accelerated stability assessment of monoterpenes-loaded solid lipid nanoparticles (SLN).
Zielińska A; Ferreira NR; Feliczak-Guzik A; Nowak I; Souto EB
Pharm Dev Technol; 2020 Sep; 25(7):832-844. PubMed ID: 32204628
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory and anti-cancer activity of citral: Optimization of citral-loaded solid lipid nanoparticles (SLN) using experimental factorial design and LUMiSizer®.
Zielińska A; Martins-Gomes C; Ferreira NR; Silva AM; Nowak I; Souto EB
Int J Pharm; 2018 Dec; 553(1-2):428-440. PubMed ID: 30385373
[TBL] [Abstract][Full Text] [Related]
5. Optimization of nimesulide-loaded solid lipid nanoparticles (SLN) by factorial design, release profile and cytotoxicity in human Colon adenocarcinoma cell line.
Campos JR; Fernandes AR; Sousa R; Fangueiro JF; Boonme P; Garcia ML; Silva AM; Naveros BC; Souto EB
Pharm Dev Technol; 2019 Jun; 24(5):616-622. PubMed ID: 30477410
[TBL] [Abstract][Full Text] [Related]
6. Key production parameters for the development of solid lipid nanoparticles by high shear homogenization.
Souto EB; Doktorovova S; Zielinska A; Silva AM
Pharm Dev Technol; 2019 Nov; 24(9):1181-1185. PubMed ID: 31354002
[TBL] [Abstract][Full Text] [Related]
7. Solid lipid nanoparticles optimized by 2
Rigon RB; Gonçalez ML; Severino P; Alves DA; Santana MHA; Souto EB; Chorilli M
Colloids Surf B Biointerfaces; 2018 Nov; 171():501-505. PubMed ID: 30081382
[TBL] [Abstract][Full Text] [Related]
8. Novel Solid Lipid Nanocarrier of Glibenclamide: A Factorial Design Approach with Response Surface Methodology.
Pandey S; Patel P; Gupta A
Curr Pharm Des; 2018; 24(16):1811-1820. PubMed ID: 29788881
[TBL] [Abstract][Full Text] [Related]
9. Formulation of solid lipid nanoparticles (SLN): the value of different alkyl polyglucoside surfactants.
Keck CM; Kovačević A; Müller RH; Savić S; Vuleta G; Milić J
Int J Pharm; 2014 Oct; 474(1-2):33-41. PubMed ID: 25108048
[TBL] [Abstract][Full Text] [Related]
10. Optimizing SLN and NLC by 2(2) full factorial design: effect of homogenization technique.
Severino P; Santana MH; Souto EB
Mater Sci Eng C Mater Biol Appl; 2012 Aug; 32(6):1375-9. PubMed ID: 24364934
[TBL] [Abstract][Full Text] [Related]
11. Characterization of ergocalciferol loaded solid lipid nanoparticles.
Patel MR; San Martin-Gonzalez MF
J Food Sci; 2012 Jan; 77(1):N8-13. PubMed ID: 22260120
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of catalase-loaded solid lipid nanoparticles based on soybean phosphatidylcholine.
Qi C; Chen Y; Huang JH; Jin QZ; Wang XG
J Sci Food Agric; 2012 Mar; 92(4):787-93. PubMed ID: 22101976
[TBL] [Abstract][Full Text] [Related]
13. Optimization of the Conditions of Solid Lipid Nanoparticles (SLN) Synthesis.
Musielak E; Feliczak-Guzik A; Nowak I
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408600
[TBL] [Abstract][Full Text] [Related]
14. Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: Effect on formulation and characterization parameters.
Shah B; Khunt D; Bhatt H; Misra M; Padh H
Eur J Pharm Sci; 2015 Oct; 78():54-66. PubMed ID: 26143262
[TBL] [Abstract][Full Text] [Related]
15. Development of DH-I-180-3 loaded lipid nanoparticle for photodynamic therapy.
Park JH; Ban SJ; Ahmed T; Choi HS; Yoon HE; Yoon JH; Choi HK
Int J Pharm; 2015 Aug; 491(1-2):393-401. PubMed ID: 26149935
[TBL] [Abstract][Full Text] [Related]
16. Hesperidin-Loaded Solid Lipid Nanoparticles: Development and Physicochemical Properties Evaluation.
Ferrari PC; Correia MK; Somer A; Ribeiro MA; Astrath NGC; Sato F; Novatski A
J Nanosci Nanotechnol; 2019 Aug; 19(8):4747-4757. PubMed ID: 30913782
[TBL] [Abstract][Full Text] [Related]
17. Diazepam-loaded solid lipid nanoparticles: design and characterization.
Abdelbary G; Fahmy RH
AAPS PharmSciTech; 2009; 10(1):211-9. PubMed ID: 19277870
[TBL] [Abstract][Full Text] [Related]
18. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
[TBL] [Abstract][Full Text] [Related]
19. Influence of surfactants on the physical stability of solid lipid nanoparticle (SLN) formulations.
Uner M; Wissing SA; Yener G; Müller RH
Pharmazie; 2004 Apr; 59(4):331-2. PubMed ID: 15125588
[TBL] [Abstract][Full Text] [Related]
20. Formulation optimization of erythromycin solid lipid nanocarrier using response surface methodology.
Sahu AK; Kumar T; Jain V
Biomed Res Int; 2014; 2014():689391. PubMed ID: 25045692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
